360 filings
Page 10 of 18
8-K
3xomdyml5x4 ew
1 Mar 13
Departure of Directors or Certain Officers
12:00am
8-K
jd74nc
1 Mar 13
Dynavax Reports Fourth Quarter and Year End 2012
12:00am
8-K
vbp86
26 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
yktrqbbil503e
25 Feb 13
Dynavax Receives Fda Complete Response Letter on Heplisavtm Biologic License Application
12:00am
8-K
veks6hu qlit
7 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
u27kot2q 3epsk
5 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
wkydoj
19 Dec 12
Entry into a Material Definitive Agreement
12:00am
8-K
l54xxe9i i3c
15 Nov 12
Dynavax Announces Fda Advisory Committee Meeting Outcome
12:00am
8-K
tdkoz66c1j8gfms4l8
2 Nov 12
Departure of Directors or Certain Officers
12:00am
8-K
yhkv0tvsklzohz1mp
2 Nov 12
Dynavax Reports Third Quarter 2012 Financial Results
12:00am
8-K
37m7dggp
1 Nov 12
Other Events
12:00am
8-K
7aejv2k7t3dhmznw3
28 Aug 12
Other Events
12:00am
8-K
htjn9t
23 Aug 12
Other Events
12:00am
8-K
d2bv rsc1uf
15 Aug 12
Entry into a Material Definitive Agreement
12:00am
8-K
87kcpmqyi699 r5wrc
1 Aug 12
Results of Operations and Financial Condition
12:00am
8-K
a3citp wwa6xo80gtiy
24 Jul 12
Other Events
12:00am
8-K
gdkzlvm
26 Jun 12
Other Events
12:00am
8-K
3xaclme
1 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ua8bo22fln71v6sbq5z
10 May 12
Dynavax Announces Proposed Public Offering of Common Stock
12:00am
8-K
9jji252s rl1
8 May 12
Other Events
12:00am